Current Neuro-Oncology
Volume
28 Number 24
31 August 2026
Home > Publications > Current Neuro-Oncology > Volume 28, Year 2026 > Number 24, 31 August
Zhu W, Rao J, Hu G, Wang R, Luo X, Li Q.
Tumor
treating fields plus temozolomide maintenance after
radiochemotherapy in Chinese grade 4 gliomas: Efficacy and
predictive biomarkers.
Neurooncol
Adv. 2026 Jul 23;8(1):vdag194. doi:
10.1093/noajnl/vdag194. PMID:
42630691. ˍ
Haedenkamp T, Fischl A, Gerken M, Rothhammer-Hampl T, Fassbender
A, Klein V, Liu I, Layer K, Suboh A, Luger AL, Mildenberger I,
Weller J, Kebir S, Schmidt T, Zeyen T, Glas M, Herrlinger U, Onken
J, Platten M, Schmidt-Graf F, Steinbach JP, Linker R,
Riemenschneider MJ, Proescholdt M, Maurer J, Bumes E, Hau P.
Lomustine with or without procarbazine
in recurrent glioblastoma-A propensity score matching analysis.
Neurooncol
Adv. 2026 Jul 31;8(1):vdag197. doi:
10.1093/noajnl/vdag197. PMID:
42639298. ˍ
Tang PLY, Smits M, van Werkhoven ED, Nout RA, Warnert EAH, Méndez
Romero A.
Recurrence distance analysis
for clinical target volume optimization in glioblastoma.
Clin
Transl Radiat Oncol. 2026 Aug 12;61:101258. doi:
10.1016/j.ctro.2026.101258. PMID:
42633158. ˍ